{
    "nctId": "NCT01827969",
    "briefTitle": "Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy",
    "officialTitle": "Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Tumor",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1,
    "primaryOutcomeMeasure": "Evaluate the effectiveness of ablathermy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Invasive Breast Carcinoma with histologically confirmed hormone receptor analysis, the grade of the tumor, the expression of Her-2.\n* Lesion classified T1-T2-T3 unifocal or multifocal with or without associated microcalcifications\n* Lesion recognizable and identifiable in MRI\n* Indication of mastectomy with or without axillary\n* Lesion located more than 10 mm from the skin, the nipple and pectoralis major\n* No cons-indication to MRI (pacemaker)\n* Women whose age is \u2265 18 years\n* If premenopausal patient: patient contraceptives\n* Patient has signed informed consent\n* Affiliation to a social security scheme\n\nExclusion Criteria:\n\n* Tumor-TD T4B classified or non-palpable lesion\n* If age \\<70 years: no indication of adjuvant chemotherapy and neoadjuvant\n* MRI lesions have not been identified, located within 10 mm of the skin and pectoral muscle, greater than 25 mm diameter\n* Inability to hold still in the prone position, arms extended, for 30 minutes\n* Contraindication to MRI\n* Patient deprived of liberty and major subject of a measure of legal protection or unable to consent\n* Patient participating in another interventional clinical trial within 30 days prior to baseline and during the trial.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}